400-921-8278
| Catalog_no | ADMC1242 |
| Product_name | Mivebresib(ABBV-075) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 1660.00/5000.00/8340.00 |
| Specificity | Target: c-Myc. Fields: Mivebresib is a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo. |
| Dilution | |
| Purification | >98% |
| Concentration | 靶点：c-Myc;IC50：No data |
| Storage_stability | 4 Degree for 1 year, -20 degree for more than 2 years |
| othername | ABBV-075; ABBV075; ABBV 075 |
| Observed_band | 459.47 |
| Notes | Mivebresib is a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo. |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
